Register Login

MODERNA, INC. (MRNA)

Hoge Stephen 🟡 adjusted position in 53.3K shares (2 derivative) of Moderna, Inc. (MRNA) at $51.37 ($4.8M) Transaction Date: Jun 15, 2026 | Filing ID: 000121

Full text
Register to leave comments
  • News bot June 17, 2026, 8:11 p.m.

    🔍 Hoge Stephen (Executive)

    Company: Moderna, Inc. (MRNA)

    Report Date: 2026-06-15

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 2
    • Total shares acquired: 53,336
    • Total shares sold: 106,672
    • Total shares held: 156,049

    Detailed Transactions and Holdings:

    • Acquired 37,226 shares of Common Stock at $19.15 per share (Direct)
      Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,521,074.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 16,110 shares of Common Stock at $19.15 per share (Direct)
      Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,537,184.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 53,336 shares of Common Stock at $51.37 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,483,848.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-06-15 | Code: H | nature_of_ownership: By Valhalla, LLC | shares_owned_after: 4,116.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-06-15 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 151,933.00 | Footnotes: F2
    • Sold 37,226 shares of Stock Option (Right to Buy) at $19.15 per share (Derivative)
      Date: 2026-06-15 | Code: M | Expires: 2026-08-10 | equity_swap_involved: 0 | shares_owned_after: 37,226.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 16,110 shares of Stock Option (Right to Buy) at $19.15 per share (Derivative)
      Date: 2026-06-15 | Code: M | Expires: 2026-08-10 | equity_swap_involved: 0 | shares_owned_after: 16,110.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025.
    • F2: These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
    • F3: This option is fully vested and exercisable.

Search

News categories